Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH), 46997-46998 [E9-21991]

Download as PDF Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting cprice-sewell on DSK2BSOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, NIDDK. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Institute of Diabetes and Digestive and Kidney Diseases, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors, NIDDK. Date: October 15–16, 2009. Time: October 15, 2009, 8:15 a.m. to 3:50 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 10, 10 Center Drive, Conference Room 9S235, Bethesda, MD 20892. Time: October 16, 2009, 8:15 a.m. to 4:45 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 10, 10 Center Drive, Conference Room 9S235 Bethesda, MD 20892. Contact Person: Ira W. Levin, PhD, Director, Division of Intramural Research, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, 301–496–6844, iwl@helix.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; VerDate Nov<24>2008 15:23 Sep 11, 2009 Jkt 217001 Dated: September 3, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–21997 Filed 9–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel, Cell Bank. Date: October 8, 2009. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20814 (Telephone Conference Call). Contact Person: Alicja L Markowska, PhD, DSC, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892. 301–496–9666. markowska@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel, Genetics of Aging in Drosophila. Date: October 20, 2009. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Elaine Lewis, PhD, Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Building, Suite 2C212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892. 301–402–7707. elainelewis@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel, Neuroendocrine and Reproductive Aging. PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 46997 Date: December 2, 2009. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, 2C212, Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Rebecca J. Ferrell, PhD, Scientific Review Officer, National Institute on Aging, Gateway Building 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892. 301–402–7703. ferrellrj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: September 3, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–21999 Filed 9–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., October 13, 2009 (Closed). 8 a.m.–5 p.m., October 14, 2009 (Closed). Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone (703) 684–5900, Fax (703) 684– 1403. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Purpose: The Safety and Occupational Health Study section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. E:\FR\FM\14SEN1.SGM 14SEN1 46998 Federal Register / Vol. 74, No. 176 / Monday, September 14, 2009 / Notices Matters to be Discussed: The meeting will convene to address matters related to the conduct of Study section business and for the study section to consider safety and occupational health-related grant applications. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, PhD, NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, Telephone (404) 498–2511, Fax (404) 498–2571. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 3, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–21991 Filed 9–11–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health cprice-sewell on DSK2BSOYB1PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Public Forums Notice is hereby given of two forums of the working groups of the NIH Scientific Management Review Board: Deliberating Organizational Changes and Effectiveness Working Group and Substance Use, Abuse and Addition Working Group. The forums will serve as the first among a series of sessions for gathering information on the agency’s organizational structure and recommendations for enhancing the NIH mission through greater agency flexibility and responsiveness. The forums will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The input from these meetings will be summarized in a report that will be presented to the Scientific Management Review Board in open session at an upcoming meeting. Name of Committee: Substance Use, Abuse, and Addiction Working Group of the Scientific Management Review Board. Date: September 23, 2009. Open: 8 a.m. to 3 p.m. Agenda: Presentation and discussion will include an overview of the science of substance use, abuse, and addiction and the public health needs in this area of research. VerDate Nov<24>2008 15:23 Sep 11, 2009 Jkt 217001 Place: National Institutes of Health, Building 60, Chapel and Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892. Name of Committee: Deliberating Organizational Change and Effectiveness Working Group of the Scientific Management Review Board. Date: September 24, 2009. Open: 8 a.m. to 3 p.m. Agenda: Presentations and discussion will include an overview of NIH mission and function from scientific and stakeholder perspectives, including elaboration upon the principles and attributes fundamental to its success. Place: National Institutes of Health, Building 60, Chapel and Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892. Contact Person: Dr. Lyric Jorgenson, PhD, NIH–AAAS Science and Technology Policy Fellow, Office of Science Policy, Office of the Director, NIH, National Institutes of Health, Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892, smrb@mail.nih.gov, (301) 496–6837. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. The meeting will also be webcast. The draft meeting agenda and other information about the SMRB, including information about access to the webcast, will be available at http://smrb.od.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxis, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: August 28, 2009. Lynn Hudson, Acting Director, Office of Biotechnology Activities. [FR Doc. E9–22000 Filed 9–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Advisory Child Health and Human Development Council, September 21, 2009, 8 a.m. to September 21, 2009, 5 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD 20892 which was published in the Federal PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Register on September 1, 2009, 74 FR 54224. This notice is being amended to provide additional attendee viewing and Videocast access instructions for open session of Council. In order to facilitate public attendance at the open session of Council, reserve seating will be made available to the first five individuals reserving seats in the main meeting room, Conference Room 6. Please Contact Ms. Lisa Kaeser, Program and Public Liaison Office, NICHD, at 301– 496–0536 to make your reservation. Additional seating will be available in the meeting overflow rooms, Conference Rooms 7 and 8. Individuals will also be able to view the meeting via NIH Videocast. Please go to the following link for Videocast access instructions at: http://www.nichd.nih.gov/about/ overview/advisory/nachhd/virtualmeeting-200910.cfm. The meeting is partially closed to the public. Dated: September 3, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–21998 Filed 9–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0667] [FDA 225–09–0010] Memorandum of Understanding With Duke University AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and Duke University. The purpose of this MOU is to establish a framework for collaboration between the Parties and for pursuing specific collaborative projects. This collaboration between the Parties shall be known as the Cardiac Safety Research Consortium. DATES: The agreement became effective August 4, 2009. FOR FURTHER INFORMATION CONTACT: Wendy R. Sanhai, Office of the Commissioner (HZ–1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–7867, FAX: 301–827–5891. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), E:\FR\FM\14SEN1.SGM 14SEN1

Agencies

[Federal Register Volume 74, Number 176 (Monday, September 14, 2009)]
[Notices]
[Pages 46997-46998]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21991]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Safety and Occupational Health Study Section (SOHSS), National 
Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), CDC announces the following meeting of 
the aforementioned committee:

    Times and Dates: 8 a.m.-5 p.m., October 13, 2009 (Closed). 8 
a.m.-5 p.m., October 14, 2009 (Closed).
    Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, 
Virginia 22314, Telephone (703) 684-5900, Fax (703) 684-1403.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Purpose: The Safety and Occupational Health Study section will 
review, discuss, and evaluate grant application(s) received in 
response to the Institute's standard grants review and funding 
cycles pertaining to research issues in occupational safety and 
health, and allied areas.
    It is the intent of NIOSH to support broad-based research 
endeavors in keeping with the Institute's program goals. This will 
lead to improved understanding and appreciation for the magnitude of 
the aggregate health burden associated with occupational injuries 
and illnesses, as well as to support more focused research projects, 
which will lead to improvements in the delivery of occupational 
safety and health services, and the prevention of work-related 
injury and illness. It is anticipated that research funded will 
promote these program goals.

[[Page 46998]]

    Matters to be Discussed: The meeting will convene to address 
matters related to the conduct of Study section business and for the 
study section to consider safety and occupational health-related 
grant applications. Agenda items are subject to change as priorities 
dictate.
    Contact Person for More Information: Price Connor, PhD, NIOSH 
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta, 
Georgia 30333, Telephone (404) 498-2511, Fax (404) 498-2571.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: September 3, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-21991 Filed 9-11-09; 8:45 am]
BILLING CODE 4163-18-P